Noviotech Campus
Menu

You are here:

Pulse. Magazine

Tinybots: “We’re here to make history, not to make a quick buck”

What is the key to success? Is it about personal traits, like talent, intelligence or creativity – and what about your resources, like money, a vast network and power? Some think it has everything to do with grit: the passion and perseverance one dedicates to reaching long-term and meaningful goals. In GOING GRIT we explore the stories of innovators in health & high tech. We dive into their inspirations and motivations as we try to understand their leitmotiv. Will we get a glimpse of their grit factor? This edition: Wang Long Li, founder and CEO of health innovation company Tinybots.

Full story

Paving the way – #womenintech

The health and high tech industries are still seen as predominantly male, but in fact women are paving the way for the future. We spoke to three women about working in these industries – both the fun parts and downsides – and their tips and best practices for future female talent.

Christelle Le Cam, Technology & Quality Support Senior Director at NXP, Kasia Nowak, Technical Director at Nexperia and Anna Walesieniuk, Product Marketing Director at Ampleon will tell about their role as women in tech.

Read all stories

Big Data robot lab to be established at Noviotech Campus

The Big Data Robot lab is being developed in cooperation with Fontys University of Applied Sciences Eindhoven and the goal is to establish the robot lab at Noviotech Campus in Nijmegen.

According to Radboud University professor Wilhelm Huck, the chemistry of the 21st century is Big Chemistry.  We spoke to him about his ground-breaking plans to build a new world-class infrastructure for research into complex molecular systems.

Interview - Wilhelm Huck

Tracking Tuberculosis -pinkRF knows precisely how, when and where

Viral diseases can radically change the world as we know it, with a huge impact on society. If anything, the COVID-19 pandemic taught us that. Yet there are several infectious diseases that still require better treatments and procedures for diagnosis. One of them is tuberculosis: in 2020 the second leading infectious killer after COVID-19, according to the World Health Organization (WHO). Even though we can already treat its symptoms with antibiotics, there are still challenges when it comes to preventing it from spreading. Klaus Werner however, CEO and co-founder of pinkRF, plans on changing that.

Interview with Klaus Werner

Innovation Origins

Our newsroom weekly publishes articles and news items about the latest innovations in health & high tech – written by our contentpartner Innovation Origins. The editorial office selected five articles they don’t want you to miss out on, presenting: the Innovation Originals. The editorial office selected four articles from the past year we don’t want you to miss out on, presenting: the Innovation Originals

  • Breast cancer drug on its way to approval
  • Sustainable chips: Wiring from gold to copper to … nothing?
  • Innovative anti-bleeding bandage
  • World’s largest pathology database launches in Nijmegen
All articles: Innovation Originals

When your world turns dark

Joyce de Ruiter – Ambassador of the Usher Syndrome Foundation

Joyce de Ruiter was sixteen years old when her parents had to tell her that she’d been diagnosed with Usher syndrome: an inherited disorder which deteriorates hearing and especially vision during life, often resulting in people becoming deaf and blind. “Finally, the puzzle pieces of hearing loss and night blindness had been named, but at the same time your whole future outlook wavers.” Joyce tells us about the impact this diagnosis had on her life and how it gradually turned into something she now draws strength and courage from.

Full article
All stories in PULSE Magazine